NICE’s decision not to approve Zytiga ‘frustrating’, says ICR
16th July 2021 Uncategorised 0Zytiga is used for the treatment of newly diagnosed, advanced prostate cancer patients
More: NICE’s decision not to approve Zytiga ‘frustrating’, says ICR
Source: News